About Endoclear
Endoclear is a company based in San Ramon (United States) founded in 2009 by Brad Vazales was acquired by Avanos in November 2019. Endoclear has raised $8.37 million across 7 funding rounds from investors including Avanos. Endoclear operates in a competitive market with competitors including Belluscura, Lungpacer, hemovent, ALung and OneBreath, among others.
- Headquarter San Ramon, United States
- Founders Brad Vazales
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Endoclear Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Endoclear
Endoclear has successfully raised a total of $8.37M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $782.79 thousand completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Endoclear
Endoclear has secured backing from 1 investor. Prominent investors backing the company include Avanos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical devices for pain management and enteral feeding are manufactured.
|
Locked | Locked | Locked |
Investor details for Endoclear
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Endoclear
Investment portfolio details for Endoclear
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Endoclear
Detailed financials for Endoclear
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Endoclear Comparisons
Peer comparison for Endoclear
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Endoclear
Endoclear operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, Lungpacer, hemovent, ALung and OneBreath, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of medical devices for laparoscopic procedures
|
|
| Locked | Locked | Locked |
Neurostimulation-based pacer for diaphragm strength is developed.
|
|
| Locked | Locked | Locked |
Equipment for extracorporeal life support and CO2 removal is developed.
|
|
| Locked | Locked | Locked |
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
|
|
| Locked | Locked | Locked |
Portable mechanical ventilators for intensive care patients are developed.
|
|
| Locked | Locked | Locked |
Medical devices for emergency airway management are developed.
|
Detailed competitors of Endoclear
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Endoclear
Complete news archive for Endoclear
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Endoclear
Endoclear was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Endoclear is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.
Brad Vazales is the current CEO of Endoclear. They have also founded this company.
Endoclear is a funded company, having raised a total of $8.37M across 7 funding rounds to date.
Endoclear develops devices to clear away film and blockages in breathing tubes. The company has developed endOclear, a device that removes mucus and secretions, biofilm, and bacteria from ventilated patients endotracheal tubes and is meant for patients who need a ventilator for more than 48 hours. It combines a clearing technology that physically removes mucus, secretions, and biofilm from the walls of endotracheal tubes in a closed system with suction.
Endoclear's top competitors include Belluscura, Lungpacer and hemovent.
Endoclear has 1 investor. Key investors include Avanos.